Evidence map›Paper›PMID 36530209›Full record

ArticleInternational review of financial analysis2021

Immunizing markets against the pandemic: COVID-19 vaccinations and stock volatility around the world.

Wael Rouatbi, Ender Demir, Renatas Kizys, Adam Zaremba

Open access · greenAbstract read
In one paragraph

Article in International review of financial analysis, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
33.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 129 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. COVID-19 vaccines and global stock markets.Finance research letters · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 4 countries.

Wael RouatbiMontpellier Business School, 2300 Avenue des Moulins, 34185 Montpellier Cedex 4, France.
Ender DemirIstanbul Medeniyet University, Dumlupınar D100 Karayolu No:98, 34720 Kadıköy/İstanbul, Turkey.
Renatas KizysDepartment of Banking and Finance, Southampton Business School, University of Southampton, Room 1013, Building 4, Highfield Campus, Southampton SO17 1BJ, United Kingdom.
Adam ZarembaMontpellier Business School, 2300 Avenue des Moulins, 34185 Montpellier Cedex 4, France.
Istanbul Medeniyet University · TRMontpellier Business School · FRUniversité de Montpellier · FRUniversity of Southampton · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The COVID-19 pandemic has exerted a noteworthy impact on stock market volatility around the world. Can vaccination programs revert these adverse effects? To answer this question, we scrutinize daily data from 66 countries from January 1, 2020 to April 30, 2021. We provide convincing evidence that COVID-19 vaccination assists in stabilizing the global equity markets. The drop in volatility is robust to many considerations and does not result solely from either the pandemic itself or the government policy responses-the negative correlation remains significant after controlling for these factors. The impact of vaccinations is relatively stronger within developed markets than in emerging ones.

Indexed as

COVID-19 pandemicNovel coronavirusStock market volatilityVaccinations

Identifiers

PMID36530209
PMCPMC8225290
OpenAlexW3141401153

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.